APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Non-Invasive Helicobacter Pylori Detection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-Invasive Helicobacter Pylori Detection Market Outlook and Growth Opportunities 2026

Report ID 17442718054 July 2026197 pages

Choose your research edition.

Industry ResearchNon-Invasive Helicobacter Pylori Detection Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Invasive Helicobacter Pylori Detection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Non-Invasive Helicobacter Pylori Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Invasive Helicobacter Pylori Detection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Invasive Helicobacter Pylori Detection Market Analysis and Forecast 2026-2032174 pages · $4,950 USD

Market perspective

The global Non-Invasive Helicobacter Pylori Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-Invasive Helicobacter Pylori Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Invasive Helicobacter Pylori Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Invasive Helicobacter Pylori Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-Invasive Helicobacter Pylori Detection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-Invasive Helicobacter Pylori Detection market include Biosynex, Hysen Biotech, Quidel Corporation, Standard Diagnostics, Teco Diagnostics, Assure Tech, Beier Bioengineering, Liming Bio and New Horizon Health, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-Invasive Helicobacter Pylori Detection market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Invasive Helicobacter Pylori Detection and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Invasive Helicobacter Pylori Detection revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-Invasive Helicobacter Pylori Detection market.

Non-Invasive Helicobacter Pylori Detection Segment by Company

Biosynex

Hysen Biotech

Quidel Corporation

Standard Diagnostics

Teco Diagnostics

Assure Tech

Beier Bioengineering

Liming Bio

New Horizon Health

Thermo Fisher Scientific

Shanghai Chemtron Biotech

Isia Biotech

Non-Invasive Helicobacter Pylori Detection Segment by Type

Serology Test

Urea Breath Test(UBT)

Stool Antigen Test

Secretion Antibody Test

Others

Non-Invasive Helicobacter Pylori Detection Segment by Application

Medical

Household

Non-Invasive Helicobacter Pylori Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-Invasive Helicobacter Pylori Detection status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-Invasive Helicobacter Pylori Detection key companies, revenue, market share, and recent developments.

3. To split the Non-Invasive Helicobacter Pylori Detection breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-Invasive Helicobacter Pylori Detection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-Invasive Helicobacter Pylori Detection significant trends, drivers, influence factors in global and regions.

6. To analyze Non-Invasive Helicobacter Pylori Detection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Invasive Helicobacter Pylori Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Invasive Helicobacter Pylori Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Invasive Helicobacter Pylori Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Invasive Helicobacter Pylori Detection industry.

Chapter 3: Detailed analysis of Non-Invasive Helicobacter Pylori Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-Invasive Helicobacter Pylori Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-Invasive Helicobacter Pylori Detection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-Invasive Helicobacter Pylori Detection Industry Trends Table 2. Non-Invasive Helicobacter Pylori Detection Industry Drivers Table 3. Non-Invasive Helicobacter Pylori Detection Industry Opportunities and Challenges Table 4. Non-Invasive Helicobacter Pylori Detection Industry Restraints Table 5. Global Non-Invasive Helicobacter Pylori Detection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-Invasive Helicobacter Pylori Detection Revenue Share by Company (2021-2026) Table 7. Global Non-Invasive Helicobacter Pylori Detection Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-Invasive Helicobacter Pylori Detection Key Company Manufacturing Base & Headquarters Table 9. Global Non-Invasive Helicobacter Pylori Detection Company, Product Type & Application Table 10. Global Non-Invasive Helicobacter Pylori Detection Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-Invasive Helicobacter Pylori Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Serology Test Table 15. Significant Companies of Urea Breath Test(UBT) Table 16. Significant Companies of Stool Antigen Test Table 17. Significant Companies of Secretion Antibody Test Table 18. Significant Companies of Others Table 19. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type (2021-2026) Table 23. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Medical Table 25. Significant Companies of Household Table 26. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application (2021-2026) Table 30. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application (2027-2032) Table 31. Global Non-Invasive Helicobacter Pylori Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Region (2021-2026) Table 34. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Region (2027-2032) Table 36. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Non-Invasive Helicobacter Pylori Detection Sales Value Market Share by Country (2021-2026) Table 39. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Non-Invasive Helicobacter Pylori Detection Sales Value Market Share by Country (2027-2032) Table 41. Biosynex Company Information Table 42. Biosynex Business Overview Table 43. Biosynex Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Biosynex Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 45. Biosynex Recent Development Table 46. Hysen Biotech Company Information Table 47. Hysen Biotech Business Overview Table 48. Hysen Biotech Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Hysen Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 50. Hysen Biotech Recent Development Table 51. Quidel Corporation Company Information Table 52. Quidel Corporation Business Overview Table 53. Quidel Corporation Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Quidel Corporation Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 55. Quidel Corporation Recent Development Table 56. Standard Diagnostics Company Information Table 57. Standard Diagnostics Business Overview Table 58. Standard Diagnostics Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Standard Diagnostics Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 60. Standard Diagnostics Recent Development Table 61. Teco Diagnostics Company Information Table 62. Teco Diagnostics Business Overview Table 63. Teco Diagnostics Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Teco Diagnostics Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 65. Teco Diagnostics Recent Development Table 66. Assure Tech Company Information Table 67. Assure Tech Business Overview Table 68. Assure Tech Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Assure Tech Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 70. Assure Tech Recent Development Table 71. Beier Bioengineering Company Information Table 72. Beier Bioengineering Business Overview Table 73. Beier Bioengineering Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Beier Bioengineering Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 75. Beier Bioengineering Recent Development Table 76. Liming Bio Company Information Table 77. Liming Bio Business Overview Table 78. Liming Bio Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Liming Bio Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 80. Liming Bio Recent Development Table 81. New Horizon Health Company Information Table 82. New Horizon Health Business Overview Table 83. New Horizon Health Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. New Horizon Health Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 85. New Horizon Health Recent Development Table 86. Thermo Fisher Scientific Company Information Table 87. Thermo Fisher Scientific Business Overview Table 88. Thermo Fisher Scientific Non-Invasive Helicobacter Pylori Detection Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Thermo Fisher Scientific Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 90. Thermo Fisher Scientific Recent Development Table 91. Shanghai Chemtron Biotech Company Information Table 92. Shanghai Chemtron Biotech Business Overview Table 93. Shanghai Chemtron Biotech Non-Invasive Helicobacter Pylori Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Shanghai Chemtron Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 95. Shanghai Chemtron Biotech Recent Development Table 96. Isia Biotech Company Information Table 97. Isia Biotech Business Overview Table 98. Isia Biotech Non-Invasive Helicobacter Pylori Detection Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Isia Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio Table 100. Isia Biotech Recent Development Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Non-Invasive Helicobacter Pylori Detection Product Image Figure 2. Global Non-Invasive Helicobacter Pylori Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Invasive Helicobacter Pylori Detection Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Invasive Helicobacter Pylori Detection Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Serology Test Image Figure 8. Urea Breath Test(UBT) Image Figure 9. Stool Antigen Test Image Figure 10. Secretion Antibody Test Image Figure 11. Others Image Figure 12. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type (2021-2032) Figure 15. Medical Image Figure 16. Household Image Figure 17. Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application (2021-2032) Figure 20. Global Non-Invasive Helicobacter Pylori Detection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032) & (US$ Million) Figure 23. North America Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032) & (US$ Million) Figure 29. South America Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Serology Test
  • Urea Breath Test(UBT)
  • Stool Antigen Test
  • Secretion Antibody Test
  • Others
Applications
  • Medical
  • Household
Companies covered
  • Biosynex
  • Hysen Biotech
  • Quidel Corporation
  • Standard Diagnostics
  • Teco Diagnostics
  • Assure Tech
  • Beier Bioengineering
  • Liming Bio
  • New Horizon Health
  • Thermo Fisher Scientific
  • Shanghai Chemtron Biotech
  • Isia Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Invasive Helicobacter Pylori Detection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Invasive Helicobacter Pylori Detection Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-Invasive Helicobacter Pylori Detection Market Dynamics
  1. 2.1 Non-Invasive Helicobacter Pylori Detection Industry Trends
  2. 2.2 Non-Invasive Helicobacter Pylori Detection Industry Drivers
  3. 2.3 Non-Invasive Helicobacter Pylori Detection Industry Opportunities and Challenges
  4. 2.4 Non-Invasive Helicobacter Pylori Detection Industry Restraints
3 Non-Invasive Helicobacter Pylori Detection Market by Company
  1. 3.1 Global Non-Invasive Helicobacter Pylori Detection Company Revenue Ranking in 2025
  2. 3.2 Global Non-Invasive Helicobacter Pylori Detection Revenue by Company (2021-2026)
  3. 3.3 Global Non-Invasive Helicobacter Pylori Detection Company Ranking (2024-2026)
  4. 3.4 Global Non-Invasive Helicobacter Pylori Detection Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-Invasive Helicobacter Pylori Detection Company Product Type and Application
  6. 3.6 Global Non-Invasive Helicobacter Pylori Detection Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-Invasive Helicobacter Pylori Detection Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-Invasive Helicobacter Pylori Detection Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-Invasive Helicobacter Pylori Detection Market by Type
  1. 4.1 Non-Invasive Helicobacter Pylori Detection Type Introduction
  2. 4.1.1 Serology Test
  3. 4.1.2 Urea Breath Test(UBT)
  4. 4.1.3 Stool Antigen Test
  5. 4.1.4 Secretion Antibody Test
  6. 4.1.5 Others
  7. 4.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type
  8. 4.2.1 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Type (2021-2032)
  10. 4.2.3 Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type (2021-2032)
5 Non-Invasive Helicobacter Pylori Detection Market by Application
  1. 5.1 Non-Invasive Helicobacter Pylori Detection Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Household
  4. 5.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application
  5. 5.2.1 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Application (2021-2032)
  7. 5.2.3 Global Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application (2021-2032)
6 Non-Invasive Helicobacter Pylori Detection Regional Value Analysis
  1. 6.1 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032)
  7. 6.3.2 North America Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032)
  10. 6.4.2 Europe Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032)
  16. 6.6.2 South America Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-Invasive Helicobacter Pylori Detection Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-Invasive Helicobacter Pylori Detection Sales Value Share by Country, 2025 VS 2032
7 Non-Invasive Helicobacter Pylori Detection Country-level Value Analysis
  1. 7.1 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-Invasive Helicobacter Pylori Detection Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-Invasive Helicobacter Pylori Detection Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-Invasive Helicobacter Pylori Detection Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-Invasive Helicobacter Pylori Detection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Biosynex
  2. 8.1.1 Biosynex Company Information
  3. 8.1.2 Biosynex Business Overview
  4. 8.1.3 Biosynex Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Biosynex Non-Invasive Helicobacter Pylori Detection Product Portfolio
  6. 8.1.5 Biosynex Recent Developments
  7. 8.2 Hysen Biotech
  8. 8.2.1 Hysen Biotech Company Information
  9. 8.2.2 Hysen Biotech Business Overview
  10. 8.2.3 Hysen Biotech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hysen Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio
  12. 8.2.5 Hysen Biotech Recent Developments
  13. 8.3 Quidel Corporation
  14. 8.3.1 Quidel Corporation Company Information
  15. 8.3.2 Quidel Corporation Business Overview
  16. 8.3.3 Quidel Corporation Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Quidel Corporation Non-Invasive Helicobacter Pylori Detection Product Portfolio
  18. 8.3.5 Quidel Corporation Recent Developments
  19. 8.4 Standard Diagnostics
  20. 8.4.1 Standard Diagnostics Company Information
  21. 8.4.2 Standard Diagnostics Business Overview
  22. 8.4.3 Standard Diagnostics Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Standard Diagnostics Non-Invasive Helicobacter Pylori Detection Product Portfolio
  24. 8.4.5 Standard Diagnostics Recent Developments
  25. 8.5 Teco Diagnostics
  26. 8.5.1 Teco Diagnostics Company Information
  27. 8.5.2 Teco Diagnostics Business Overview
  28. 8.5.3 Teco Diagnostics Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teco Diagnostics Non-Invasive Helicobacter Pylori Detection Product Portfolio
  30. 8.5.5 Teco Diagnostics Recent Developments
  31. 8.6 Assure Tech
  32. 8.6.1 Assure Tech Company Information
  33. 8.6.2 Assure Tech Business Overview
  34. 8.6.3 Assure Tech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Assure Tech Non-Invasive Helicobacter Pylori Detection Product Portfolio
  36. 8.6.5 Assure Tech Recent Developments
  37. 8.7 Beier Bioengineering
  38. 8.7.1 Beier Bioengineering Company Information
  39. 8.7.2 Beier Bioengineering Business Overview
  40. 8.7.3 Beier Bioengineering Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Beier Bioengineering Non-Invasive Helicobacter Pylori Detection Product Portfolio
  42. 8.7.5 Beier Bioengineering Recent Developments
  43. 8.8 Liming Bio
  44. 8.8.1 Liming Bio Company Information
  45. 8.8.2 Liming Bio Business Overview
  46. 8.8.3 Liming Bio Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Liming Bio Non-Invasive Helicobacter Pylori Detection Product Portfolio
  48. 8.8.5 Liming Bio Recent Developments
  49. 8.9 New Horizon Health
  50. 8.9.1 New Horizon Health Company Information
  51. 8.9.2 New Horizon Health Business Overview
  52. 8.9.3 New Horizon Health Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  53. 8.9.4 New Horizon Health Non-Invasive Helicobacter Pylori Detection Product Portfolio
  54. 8.9.5 New Horizon Health Recent Developments
  55. 8.10 Thermo Fisher Scientific
  56. 8.10.1 Thermo Fisher Scientific Company Information
  57. 8.10.2 Thermo Fisher Scientific Business Overview
  58. 8.10.3 Thermo Fisher Scientific Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific Non-Invasive Helicobacter Pylori Detection Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific Recent Developments
  61. 8.11 Shanghai Chemtron Biotech
  62. 8.11.1 Shanghai Chemtron Biotech Company Information
  63. 8.11.2 Shanghai Chemtron Biotech Business Overview
  64. 8.11.3 Shanghai Chemtron Biotech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai Chemtron Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio
  66. 8.11.5 Shanghai Chemtron Biotech Recent Developments
  67. 8.12 Isia Biotech
  68. 8.12.1 Isia Biotech Company Information
  69. 8.12.2 Isia Biotech Business Overview
  70. 8.12.3 Isia Biotech Non-Invasive Helicobacter Pylori Detection Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Isia Biotech Non-Invasive Helicobacter Pylori Detection Product Portfolio
  72. 8.12.5 Isia Biotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst